BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kamal A, Elsheaita A, Abdelnabi M. Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate. World J Clin Cases 2022; 10(6): 1764-1774 [PMID: 35317156 DOI: 10.12998/wjcc.v10.i6.1764]
URL: https://www.wjgnet.com/2307-8960/full/v10/i6/1764.htm
Number Citing Articles
1
Mélusine Durand, Nicolas Nagot, Quynh Bach Thi Nhu, Amélie Vizeneux, Linh Le Thi Thuy, Huong Thi Duong, Binh Nguyen Thanh, Delphine Rapoud, Roselyne Vallo, Catherine Quillet, Hong Thi Tran, Laurent Michel, Thanh Nham Thi Tuyet, Oanh Khuat Thi Hai, Vinh Vu Hai, Jonathan Feelemyer, Philippe Vande Perre, Don Des Jarlais, Khue Pham Minh, Didier Laureillard, Jean-Pierre Molès. Long-Term Persistence of Mitochondrial DNA Instability among HCV-Cured People Who Inject DrugsBiomedicines 2022; 10(10): 2541 doi: 10.3390/biomedicines10102541
2
Matilde Oliveira, Rui Gaspar, Lurdes Santos, Guilherme Macedo. High incidence of hepatocarcinoma in patients with advanced fibrosis treated with direct-acting antiviral agents for hepatitis C: A real-world retrospective studyClinics and Research in Hepatology and Gastroenterology 2024; 48(7): 102404 doi: 10.1016/j.clinre.2024.102404
3
Georgia Papadopoulou, Stavroula Petroulia, Eirini Karamichali, Alexios Dimitriadis, Dimitrios Marousis, Elisavet Ioannidou, Panagiota Papazafiri, John Koskinas, Pelagia Foka, Urania Georgopoulou. The Epigenetic Controller Lysine-Specific Demethylase 1 (LSD1) Regulates the Outcome of Hepatitis C Viral InfectionCells 2023; 12(21): 2568 doi: 10.3390/cells12212568
4
Ahmed Kamal, Marwa Metawea, Heba Omar, Mahmoud Ghallab, Ahmed Kassem, Hend Naguib. Hepatitis C Virus-Related One-Year Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled TrialJournal of Gastrointestinal Cancer 2024; 55(2): 913 doi: 10.1007/s12029-024-01035-5